See more : HORIBA, Ltd. (HRIBF) Income Statement Analysis – Financial Results
Complete financial analysis of Pee Cee Cosma Sope Limited (PCCOSMA.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Pee Cee Cosma Sope Limited, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Itamiarts.Inc (168A.T) Income Statement Analysis – Financial Results
- Global SPAC Partners Co. (GLSPU) Income Statement Analysis – Financial Results
- 890 5th Avenue Partners, Inc. (ENFAU) Income Statement Analysis – Financial Results
- Sensera Limited (SE1.AX) Income Statement Analysis – Financial Results
- Lepu Medical Technology (Beijing) Co., Ltd. (300003.SZ) Income Statement Analysis – Financial Results
Pee Cee Cosma Sope Limited (PCCOSMA.BO)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: http://www:peeceecosma.com
About Pee Cee Cosma Sope Limited
Pee Cee Cosma Sope Ltd. engages in the manufacture of soap and detergents, cleaning and polishing preparations, perfumes, and toilet preparations. Its products include laundry soap, detergent powder, and detergent cake. The firm operates under the brand name Doctor Soap. The company was founded by P. C. Jain in 1947 and is headquartered in Agra, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.34B | 1.25B | 926.93M | 822.54M | 739.56M | 760.80M | 764.43M | 709.94M | 745.49M | 805.42M | 756.73M | 820.97M | 787.67M | 267.27M | 287.62M | 363.45M |
| Cost of Revenue | 936.93M | 975.48M | 723.56M | 607.16M | 541.89M | 561.99M | 555.82M | 539.01M | 557.90M | 639.93M | 601.75M | 658.86M | 659.11M | 224.97M | 222.72M | 285.70M |
| Gross Profit | 399.50M | 269.69M | 203.37M | 215.39M | 197.67M | 198.80M | 208.61M | 170.93M | 187.59M | 165.49M | 154.98M | 162.11M | 128.56M | 42.31M | 64.90M | 77.75M |
| Gross Profit Ratio | 29.89% | 21.66% | 21.94% | 26.19% | 26.73% | 26.13% | 27.29% | 24.08% | 25.16% | 20.55% | 20.48% | 19.75% | 16.32% | 15.83% | 22.56% | 21.39% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 3.69M | 4.67M | 5.04M | 3.50M | 4.28M | 4.33M | 3.65M | 4.01M | 3.34M | 3.28M | 0.00 | 16.54M | 18.11M | 6.41M | 8.91M | 8.43M |
| Selling & Marketing | 106.57M | 86.72M | 57.14M | 43.57M | 52.24M | 46.78M | 45.35M | 43.50M | 50.15M | 13.34M | 39.89M | 41.10M | 35.88M | 15.15M | 14.89M | 15.94M |
| SG&A | 110.26M | 91.40M | 62.18M | 47.07M | 56.52M | 51.11M | 49.00M | 47.51M | 53.49M | 16.62M | 39.89M | 41.10M | 53.99M | 21.55M | 14.89M | 24.36M |
| Other Expenses | 289.25M | 175.00K | 77.00K | 344.00K | 137.16K | 80.64K | 32.47K | 236.39K | 375.54K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 399.50M | 232.21M | 181.95M | 154.43M | 170.22M | 158.00M | 150.84M | 143.13M | 148.72M | 137.36M | 122.36M | 119.63M | 114.48M | 41.47M | 41.75M | 49.22M |
| Cost & Expenses | 1.20B | 1.21B | 905.51M | 761.58M | 712.11M | 719.99M | 706.66M | 682.14M | 706.62M | 777.29M | 724.11M | 778.50M | 773.59M | 266.43M | 264.47M | 334.92M |
| Interest Income | 5.10M | 5.16M | 6.04M | 5.06M | 2.77M | 1.20M | 108.82K | 74.37K | 325.67K | 187.72K | 629.93K | 80.28K | 122.46K | 19.81K | 271.32K | 55.64K |
| Interest Expense | 3.00M | 8.58M | 3.95M | 2.23M | 1.63M | 1.34M | 1.82M | 4.70M | 7.25M | 7.60M | 3.95M | 5.13M | 5.82M | 2.19M | 2.64M | 9.13M |
| Depreciation & Amortization | 16.04M | 15.10M | 6.60M | 5.87M | 7.48M | 5.87M | 6.77M | 7.32M | 8.17M | 9.69M | 7.00M | 8.02M | 9.42M | 4.80M | 5.55M | 11.02M |
| EBITDA | 159.43M | 57.19M | 34.13M | 72.67M | 38.10M | 47.96M | 64.74M | 35.44M | 47.45M | 38.19M | 40.25M | 50.14M | 22.93M | 5.64M | 58.32M | 39.43M |
| EBITDA Ratio | 11.93% | 4.64% | 3.60% | 8.76% | 5.08% | 6.27% | 8.40% | 4.94% | 6.35% | 4.66% | 5.23% | 6.14% | 2.95% | 2.02% | -0.19% | 10.88% |
| Operating Income | 139.38M | 38.34M | 22.34M | 61.61M | 27.69M | 41.29M | 57.93M | 27.72M | 31.67M | 20.42M | 28.61M | 36.99M | 7.69M | -1.09M | 50.13M | 19.48M |
| Operating Income Ratio | 10.43% | 3.08% | 2.41% | 7.49% | 3.74% | 5.43% | 7.58% | 3.90% | 4.25% | 2.54% | 3.78% | 4.51% | 0.98% | -0.41% | 17.43% | 5.36% |
| Total Other Income/Expenses | 1.17M | -5.02M | 527.00K | 2.81M | 1.29M | -320.05K | -2.10M | -4.73M | -6.91M | -7.59M | -3.89M | -5.42M | -5.83M | -1.86M | 56.06M | -8.02M |
| Income Before Tax | 140.55M | 33.33M | 22.87M | 64.42M | 28.74M | 40.48M | 55.66M | 23.07M | 31.67M | 20.42M | 28.61M | 36.99M | 7.69M | -1.09M | 50.13M | 19.48M |
| Income Before Tax Ratio | 10.52% | 2.68% | 2.47% | 7.83% | 3.89% | 5.32% | 7.28% | 3.25% | 4.25% | 2.54% | 3.78% | 4.51% | 0.98% | -0.41% | 17.43% | 5.36% |
| Income Tax Expense | 36.11M | 8.47M | 6.01M | 16.76M | 7.68M | 12.12M | 18.98M | 7.68M | 11.18M | 6.96M | 9.84M | 12.60M | 2.01M | -30.85K | 4.25M | 7.01M |
| Net Income | 104.44M | 24.86M | 16.85M | 47.66M | 21.05M | 28.37M | 36.68M | 15.39M | 20.49M | 13.46M | 18.77M | 24.39M | 5.68M | -1.06M | 45.87M | 12.47M |
| Net Income Ratio | 7.81% | 2.00% | 1.82% | 5.79% | 2.85% | 3.73% | 4.80% | 2.17% | 2.75% | 1.67% | 2.48% | 2.97% | 0.72% | -0.40% | 15.95% | 3.43% |
| EPS | 39.50 | 9.40 | 6.37 | 18.01 | 7.96 | 10.72 | 13.86 | 5.82 | 7.70 | 5.10 | 7.10 | 9.22 | 2.15 | -0.88 | 38.23 | 10.39 |
| EPS Diluted | 39.50 | 9.40 | 6.37 | 18.01 | 7.96 | 10.72 | 13.86 | 5.82 | 7.70 | 5.10 | 7.10 | 9.22 | 2.15 | -0.88 | 38.23 | 10.39 |
| Weighted Avg Shares Out | 2.64M | 2.65M | 2.65M | 2.65M | 2.65M | 2.65M | 2.65M | 2.65M | 2.65M | 2.65M | 2.65M | 2.65M | 2.65M | 1.20M | 1.20M | 1.20M |
| Weighted Avg Shares Out (Dil) | 2.64M | 2.65M | 2.65M | 2.65M | 2.65M | 2.65M | 2.65M | 2.65M | 2.65M | 2.65M | 2.65M | 2.65M | 2.65M | 1.20M | 1.20M | 1.20M |
Source: https://incomestatements.info
Category: Stock Reports